Evercore ISI Keeps Their Buy Rating on Upstream Bio, Inc. (UPB)
at www.tipranks.com (Fri, 19-Dec 4:26 AM)
Verekitug’s Distinct TSLP Receptor Targeting Highlights Differentiated Clinical Potential for Severe Respiratory Diseases
Market Chameleon (Tue, 30-Sep 7:12 AM)
